Zabrina Brumme

Associate Professor

Simon Fraser University

Canada

Research Interests

Explore related searches

Professors in Canada Professors in Immunology Immunology professors in Canada

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Zabrina Brumme is an Associate Professor at Simon Fraser University, Canada. Her research primarily focuses on HIV and COVID-19, particularly the immune response in individuals living with HIV, the molecular epidemiology of HIV-1, and treatment strategies to promote provirus latency. Recent articles authored by Professor Brumme explore the implications of vaccination and the dynamics of HIV-1 transmission and infection in diverse populations.

Articles (11)

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2020

Year:

2020

Collaborators (7)

Mark Brockman

Associate Professor and Canada Research Chair (II)

Simon Fraser University

CANADA

View details

Ivan Sadowski

The University of British Columbia

CANADA

View details

Takayuki Chikata

Lecturer

Kumamoto University

JAPAN

View details

Jeffrey Joy

The University of British Columbia

CANADA

View details

Chanson Brumme

Assistant Professor (Partner)

University of British Columbia Faculty of Medicine

CANADA

View details

Cecilia T. Costiniuk

CANADA

View details

Jean-Pierre Routy

Professor

McGill University Health Centre

CANADA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Zabrina Brumme

Research Interests

Explore related searches

Contact this professor

About

Articles (11)

Correlates of Breakthrough SARS-CoV-2 Infections in People with HIV: Results from the CIHR CTN 328 Study

T-Cell Responses to COVID-19 Vaccines and Breakthrough Infection in People Living with HIV Receiving Antiretroviral Therapy

Small molecule inhibitors of transcriptional cyclin-dependent kinases impose HIV-1 latency, presenting “block and lock” treatment strategies

CDK8 inhibitors antagonize HIV-1 reactivation and promote provirus latency in T cells

SARS-CoV-2 Vaccine-Induced T-Cell Response after Three Doses in People Living with HIV on Antiretroviral Therapy Compared to Seronegative Controls (CTN 328 COVAXHIV Study)

Molecular Epidemiology of HIV-1 in Ghana: Subtype Distribution, Drug Resistance and Coreceptor Usage

HIV proviral genetic diversity, compartmentalization and inferred dynamics in lung and blood during long-term suppressive antiretroviral therapy

Humoral immune responses to COVID-19 vaccination in people living with HIV receiving suppressive antiretroviral therapy

Concordance of HIV transmission risk factors elucidated using viral diversification rate and phylogenetic clustering

T-cell responses to sequentially emerging viral escape mutants shape long-term HIV-1 population dynamics.

Longitudinal within-host evolution of HIV Nef-mediated CD4, HLA and SERINC5 downregulation activity: A case study

Collaborators (7)

Mark Brockman

Ivan Sadowski

Takayuki Chikata

Jeffrey Joy

Chanson Brumme

Cecilia T. Costiniuk

Jean-Pierre Routy

Make your next move.